Rybelsus 3mg contains semaglutide, a GLP-1 receptor agonist that assists glucose regulation through glucose-dependent insulin release and reduced glucagon activity.

The 3mg tablet is intended for the initial stage of treatment rather than long-term glycemic control at the full therapeutic strength. Gradual dose escalation may be used to help the body adjust to treatment.

Brand: Rybelsus

Strength: 3mg

Active Ingredient: Semaglutide

Form: Oral tablet

Pack: 10 tablets

Category: GLP-1 receptor agonist

Administration should follow the prescribed instructions carefully.